Stock Quote

Oxford University's coronavirus vaccine with AstraZeneca shows positive immune response in early trial

A potential coronavirus vaccine developed by Oxford University in the U.K. has produced an immune response in an early-stage human trial, according to newly released data published Monday in medical journal The Lancet.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.